Central Alerting System
View Alert


Originator: DHSC & NHS England and Improvement: Supply disruption alert

Issue date: 02-Dec-2020 13:50:09

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Foundation Trusts (England) - Chief Executive
  • Special Health Authorities
  • NHS Trusts (England) - Medical Director
  • CMO Urgent Messages - Non-NHS Recipients on Public Health Link
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Consultants in Communicable Diseases
  • CMO Urgent Messages - Recipients on Public Health Link
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive
  • DHSC Supply Disruption - Medicines

Action category: Action

Title: Atracurium besilate solution for injection vials and ampoules (all strengths)

Broadcast content:
Atracurium 250mg/25ml solution for injection is currently out of stock and there are limited supplies of all other strengths of atracurium injection remaining in the UK supply chain due to the recent increase in demand to support the UKs COVID-19 response.

Rocuronium is available in sufficient quantities to support the increase in demand and should be considered the first line alternative as detailed in this alert.

Given the links to covid-19 we have sent this alert to a broader mailing list than would usually receive a Supply Disruption Alert of this type. 


Additional information: This alert is not relevant to Primary Care.

Alert reference: SDA/2020/014

Action underway deadline: 04-Dec-2020

Action complete deadline: 18-Dec-2020

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency